HEADER OXIDOREDUCTASE 27-JUN-18 6GXY
TITLE TRYPAREDOXIN FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH CFT
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: TRYPAREDOXIN;
COMPND 3 CHAIN: A, B, C;
COMPND 4 SYNONYM: TRYX;
COMPND 5 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: TRYPANOSOMA BRUCEI BRUCEI;
SOURCE 3 ORGANISM_TAXID: 5702;
SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS COVALENT INHIBITOR, PHOTOREDUCTION, INHIBITOR-INDUCED DIMERIZATION,
KEYWDS 2 MONOMER-DIMER MIXTURE, OXIDOREDUCTASE
EXPDTA X-RAY DIFFRACTION
AUTHOR N.BADER,A.WAGNER,U.HELLMICH,H.SCHINDELIN
REVDAT 3 17-JAN-24 6GXY 1 REMARK
REVDAT 2 13-MAR-19 6GXY 1 JRNL
REVDAT 1 16-JAN-19 6GXY 0
JRNL AUTH A.WAGNER,T.A.LE,M.BRENNICH,P.KLEIN,N.BADER,E.DIEHL,D.PASZEK,
JRNL AUTH 2 A.K.WEICKHMANN,N.DIRDJAJA,R.L.KRAUTH-SIEGEL,B.ENGELS,
JRNL AUTH 3 T.OPATZ,H.SCHINDELIN,U.A.HELLMICH
JRNL TITL INHIBITOR-INDUCED DIMERIZATION OF AN ESSENTIAL
JRNL TITL 2 OXIDOREDUCTASE FROM AFRICAN TRYPANOSOMES.
JRNL REF ANGEW. CHEM. INT. ED. ENGL. V. 58 3640 2019
JRNL REFN ESSN 1521-3773
JRNL PMID 30605929
JRNL DOI 10.1002/ANIE.201810470
REMARK 2
REMARK 2 RESOLUTION. 1.80 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : REFMAC 5.8.0158
REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,
REMARK 3 : NICHOLLS,WINN,LONG,VAGIN
REMARK 3
REMARK 3 REFINEMENT TARGET : NULL
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00
REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL
REMARK 3 COMPLETENESS FOR RANGE (%) : 97.0
REMARK 3 NUMBER OF REFLECTIONS : 30805
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.168
REMARK 3 R VALUE (WORKING SET) : 0.165
REMARK 3 FREE R VALUE : 0.212
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800
REMARK 3 FREE R VALUE TEST SET COUNT : 1564
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 20
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.84
REMARK 3 REFLECTION IN BIN (WORKING SET) : 2125
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 92.22
REMARK 3 BIN R VALUE (WORKING SET) : 0.2590
REMARK 3 BIN FREE R VALUE SET COUNT : 105
REMARK 3 BIN FREE R VALUE : 0.2940
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 3392
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 54
REMARK 3 SOLVENT ATOMS : 624
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.20
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -0.51000
REMARK 3 B22 (A**2) : 0.09000
REMARK 3 B33 (A**2) : 0.26000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.66000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED OVERALL COORDINATE ERROR.
REMARK 3 ESU BASED ON R VALUE (A): 0.174
REMARK 3 ESU BASED ON FREE R VALUE (A): 0.147
REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL
REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.961
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.930
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT
REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3844 ; 0.009 ; 0.020
REMARK 3 BOND LENGTHS OTHERS (A): 3419 ; 0.000 ; 0.020
REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5286 ; 1.375 ; 1.967
REMARK 3 BOND ANGLES OTHERS (DEGREES): 7983 ; 3.745 ; 3.002
REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 496 ; 6.417 ; 5.000
REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 159 ;36.931 ;24.088
REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 585 ;12.234 ;15.000
REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 14 ;12.443 ;15.000
REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 556 ; 0.078 ; 0.200
REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4418 ; 0.006 ; 0.021
REMARK 3 GENERAL PLANES OTHERS (A): 826 ; 0.007 ; 0.020
REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1895 ; 1.325 ; 3.626
REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1894 ; 1.323 ; 3.625
REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2410 ; 2.108 ; 8.124
REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2411 ; 2.109 ; 8.125
REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1949 ; 1.596 ; 3.934
REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1950 ; 1.596 ; 3.935
REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2873 ; 2.487 ; 8.662
REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 4912 ; 5.980 ;24.958
REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 4695 ; 5.633 ;23.467
REMARK 3
REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 NCS RESTRAINTS STATISTICS
REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : NULL
REMARK 3 PARAMETERS FOR MASK CALCULATION
REMARK 3 VDW PROBE RADIUS : 1.20
REMARK 3 ION PROBE RADIUS : 0.80
REMARK 3 SHRINKAGE RADIUS : 0.80
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING
REMARK 3 POSITIONS
REMARK 4
REMARK 4 6GXY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 27-JUN-18.
REMARK 100 THE DEPOSITION ID IS D_1200010707.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 23-MAY-17
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 5.5
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : ESRF
REMARK 200 BEAMLINE : ID23-1
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.980004
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : PIXEL
REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS
REMARK 200 DATA SCALING SOFTWARE : AIMLESS
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32420
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800
REMARK 200 RESOLUTION RANGE LOW (A) : 50.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 97.2
REMARK 200 DATA REDUNDANCY : 4.000
REMARK 200 R MERGE (I) : 0.14100
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 6.9000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.83
REMARK 200 COMPLETENESS FOR SHELL (%) : 90.2
REMARK 200 DATA REDUNDANCY IN SHELL : 3.80
REMARK 200 R MERGE FOR SHELL (I) : 0.62400
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.800
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: 1O73
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 34.30
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.87
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 1.045 M NA-CITRATE, 0.1 M NA-ACETATE,
REMARK 280 PH 5.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 48.00450
REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: C
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLY A -1
REMARK 480
REMARK 480 ZERO OCCUPANCY ATOM
REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO
REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS
REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME;
REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):
REMARK 480 M RES C SSEQI ATOMS
REMARK 480 GLU B 133 N CA C O CB CG CD
REMARK 480 GLU B 133 OE1 OE2
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 TRP A 86 -154.17 -98.07
REMARK 500 TRP A 142 61.51 62.50
REMARK 500 THR B 12 -61.83 -120.77
REMARK 500 TRP B 86 -144.41 -115.93
REMARK 500 TRP C 86 -153.14 -108.07
REMARK 500
REMARK 500 REMARK: NULL
REMARK 525
REMARK 525 SOLVENT
REMARK 525
REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT
REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST
REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT
REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE
REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER;
REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE
REMARK 525 NUMBER; I=INSERTION CODE):
REMARK 525
REMARK 525 M RES CSSEQI
REMARK 525 HOH B 496 DISTANCE = 7.30 ANGSTROMS
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue FFN A 201
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue FFN C 201
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide FFN B 201 and CYS B
REMARK 800 40
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 6GXG RELATED DB: PDB
REMARK 900 IN 6GXG ALL COVALENT BONDS BETWEEN THE INHIBITOR AND THE PROTEIN
REMARK 900 HAVE BEEN BROKEN BY THE X-RAY BEAM. IN THIS ENTRY TWO PROTEIN-
REMARK 900 INHIBITOR COMPLEXES (A AND B CHAIN) FEATURE A MIXTURE OF
REMARK 900 COLVALENTLY BONDED AND NON-BONDED INHIBITORS WHILE THE C-CHAIN ONLY
REMARK 900 CONTAINS A NON-COVALENTLY BOUND INHIBITOR.
DBREF 6GXY A 2 144 UNP O77404 TYPX_TRYBB 2 144
DBREF 6GXY B 2 144 UNP O77404 TYPX_TRYBB 2 144
DBREF 6GXY C 2 144 UNP O77404 TYPX_TRYBB 2 144
SEQADV 6GXY GLY A -1 UNP O77404 EXPRESSION TAG
SEQADV 6GXY MET A 0 UNP O77404 EXPRESSION TAG
SEQADV 6GXY GLY A 1 UNP O77404 EXPRESSION TAG
SEQADV 6GXY GLY B -1 UNP O77404 EXPRESSION TAG
SEQADV 6GXY MET B 0 UNP O77404 EXPRESSION TAG
SEQADV 6GXY GLY B 1 UNP O77404 EXPRESSION TAG
SEQADV 6GXY GLY C -1 UNP O77404 EXPRESSION TAG
SEQADV 6GXY MET C 0 UNP O77404 EXPRESSION TAG
SEQADV 6GXY GLY C 1 UNP O77404 EXPRESSION TAG
SEQRES 1 A 146 GLY MET GLY SER GLY LEU ALA LYS TYR LEU PRO GLY ALA
SEQRES 2 A 146 THR ASN LEU LEU SER LYS SER GLY GLU VAL SER LEU GLY
SEQRES 3 A 146 SER LEU VAL GLY LYS THR VAL PHE LEU TYR PHE SER ALA
SEQRES 4 A 146 SER TRP CYS PRO PRO CYS ARG GLY PHE THR PRO VAL LEU
SEQRES 5 A 146 ALA GLU PHE TYR GLU LYS HIS HIS VAL ALA LYS ASN PHE
SEQRES 6 A 146 GLU VAL VAL LEU ILE SER TRP ASP GLU ASN GLU SER ASP
SEQRES 7 A 146 PHE HIS ASP TYR TYR GLY LYS MET PRO TRP LEU ALA LEU
SEQRES 8 A 146 PRO PHE ASP GLN ARG SER THR VAL SER GLU LEU GLY LYS
SEQRES 9 A 146 THR PHE GLY VAL GLU SER ILE PRO THR LEU ILE THR ILE
SEQRES 10 A 146 ASN ALA ASP THR GLY ALA ILE ILE GLY THR GLN ALA ARG
SEQRES 11 A 146 THR ARG VAL ILE GLU ASP PRO ASP GLY ALA ASN PHE PRO
SEQRES 12 A 146 TRP PRO ASN
SEQRES 1 B 146 GLY MET GLY SER GLY LEU ALA LYS TYR LEU PRO GLY ALA
SEQRES 2 B 146 THR ASN LEU LEU SER LYS SER GLY GLU VAL SER LEU GLY
SEQRES 3 B 146 SER LEU VAL GLY LYS THR VAL PHE LEU TYR PHE SER ALA
SEQRES 4 B 146 SER TRP CYS PRO PRO CYS ARG GLY PHE THR PRO VAL LEU
SEQRES 5 B 146 ALA GLU PHE TYR GLU LYS HIS HIS VAL ALA LYS ASN PHE
SEQRES 6 B 146 GLU VAL VAL LEU ILE SER TRP ASP GLU ASN GLU SER ASP
SEQRES 7 B 146 PHE HIS ASP TYR TYR GLY LYS MET PRO TRP LEU ALA LEU
SEQRES 8 B 146 PRO PHE ASP GLN ARG SER THR VAL SER GLU LEU GLY LYS
SEQRES 9 B 146 THR PHE GLY VAL GLU SER ILE PRO THR LEU ILE THR ILE
SEQRES 10 B 146 ASN ALA ASP THR GLY ALA ILE ILE GLY THR GLN ALA ARG
SEQRES 11 B 146 THR ARG VAL ILE GLU ASP PRO ASP GLY ALA ASN PHE PRO
SEQRES 12 B 146 TRP PRO ASN
SEQRES 1 C 146 GLY MET GLY SER GLY LEU ALA LYS TYR LEU PRO GLY ALA
SEQRES 2 C 146 THR ASN LEU LEU SER LYS SER GLY GLU VAL SER LEU GLY
SEQRES 3 C 146 SER LEU VAL GLY LYS THR VAL PHE LEU TYR PHE SER ALA
SEQRES 4 C 146 SER TRP CYS PRO PRO CYS ARG GLY PHE THR PRO VAL LEU
SEQRES 5 C 146 ALA GLU PHE TYR GLU LYS HIS HIS VAL ALA LYS ASN PHE
SEQRES 6 C 146 GLU VAL VAL LEU ILE SER TRP ASP GLU ASN GLU SER ASP
SEQRES 7 C 146 PHE HIS ASP TYR TYR GLY LYS MET PRO TRP LEU ALA LEU
SEQRES 8 C 146 PRO PHE ASP GLN ARG SER THR VAL SER GLU LEU GLY LYS
SEQRES 9 C 146 THR PHE GLY VAL GLU SER ILE PRO THR LEU ILE THR ILE
SEQRES 10 C 146 ASN ALA ASP THR GLY ALA ILE ILE GLY THR GLN ALA ARG
SEQRES 11 C 146 THR ARG VAL ILE GLU ASP PRO ASP GLY ALA ASN PHE PRO
SEQRES 12 C 146 TRP PRO ASN
HET FFN A 201 18
HET FFN B 201 18
HET FFN C 201 18
HETNAM FFN 5-(4-FLUOROPHENYL)-2-METHYL-3~{H}-THIENO[2,3-
HETNAM 2 FFN D]PYRIMIDIN-4-ONE
FORMUL 4 FFN 3(C13 H9 F N2 O S)
FORMUL 7 HOH *624(H2 O)
HELIX 1 AA1 GLY A 3 LEU A 8 1 6
HELIX 2 AA2 GLY A 24 VAL A 27 5 4
HELIX 3 AA3 CYS A 40 HIS A 58 1 19
HELIX 4 AA4 ASN A 73 GLY A 82 1 10
HELIX 5 AA5 PRO A 90 SER A 95 5 6
HELIX 6 AA6 THR A 96 PHE A 104 1 9
HELIX 7 AA7 GLN A 126 ASP A 134 1 9
HELIX 8 AA8 SER B 2 TYR B 7 5 6
HELIX 9 AA9 GLY B 24 VAL B 27 5 4
HELIX 10 AB1 CYS B 40 HIS B 58 1 19
HELIX 11 AB2 ASN B 73 LYS B 83 1 11
HELIX 12 AB3 PRO B 90 SER B 95 5 6
HELIX 13 AB4 THR B 96 GLY B 105 1 10
HELIX 14 AB5 GLN B 126 ASP B 134 1 9
HELIX 15 AB6 SER C 2 TYR C 7 5 6
HELIX 16 AB7 GLY C 24 VAL C 27 5 4
HELIX 17 AB8 CYS C 40 HIS C 58 1 19
HELIX 18 AB9 ASN C 73 LYS C 83 1 11
HELIX 19 AC1 GLN C 93 PHE C 104 1 12
HELIX 20 AC2 GLN C 126 ASP C 134 1 9
SHEET 1 AA1 2 ASN A 13 LEU A 14 0
SHEET 2 AA1 2 VAL A 21 SER A 22 -1 O VAL A 21 N LEU A 14
SHEET 1 AA2 5 LEU A 87 ALA A 88 0
SHEET 2 AA2 5 PHE A 63 SER A 69 1 N VAL A 65 O LEU A 87
SHEET 3 AA2 5 THR A 30 SER A 36 1 N TYR A 34 O VAL A 66
SHEET 4 AA2 5 THR A 111 ASN A 116 -1 O ILE A 115 N VAL A 31
SHEET 5 AA2 5 ILE A 122 GLY A 124 -1 O ILE A 123 N THR A 114
SHEET 1 AA3 2 ASN B 13 SER B 16 0
SHEET 2 AA3 2 GLY B 19 SER B 22 -1 O VAL B 21 N LEU B 14
SHEET 1 AA4 5 LEU B 87 ALA B 88 0
SHEET 2 AA4 5 PHE B 63 SER B 69 1 N LEU B 67 O LEU B 87
SHEET 3 AA4 5 THR B 30 SER B 36 1 N TYR B 34 O ILE B 68
SHEET 4 AA4 5 THR B 111 ASN B 116 -1 O ILE B 115 N VAL B 31
SHEET 5 AA4 5 ILE B 122 GLY B 124 -1 O GLY B 124 N THR B 114
SHEET 1 AA5 2 ASN C 13 LEU C 15 0
SHEET 2 AA5 2 GLU C 20 SER C 22 -1 O VAL C 21 N LEU C 14
SHEET 1 AA6 5 LEU C 87 ALA C 88 0
SHEET 2 AA6 5 PHE C 63 SER C 69 1 N LEU C 67 O LEU C 87
SHEET 3 AA6 5 THR C 30 SER C 36 1 N TYR C 34 O VAL C 66
SHEET 4 AA6 5 THR C 111 ASN C 116 -1 O ILE C 113 N LEU C 33
SHEET 5 AA6 5 ILE C 122 GLY C 124 -1 O GLY C 124 N THR C 114
LINK SG ACYS A 40 C01 FFN A 201 1555 1555 1.98
LINK SG ACYS B 40 C01 FFN B 201 1555 1555 1.96
CISPEP 1 ILE A 109 PRO A 110 0 -0.94
CISPEP 2 PHE A 140 PRO A 141 0 2.26
CISPEP 3 ILE B 109 PRO B 110 0 -3.77
CISPEP 4 PHE B 140 PRO B 141 0 3.16
CISPEP 5 ILE C 109 PRO C 110 0 1.35
CISPEP 6 PHE C 140 PRO C 141 0 6.39
SITE 1 AC1 11 TRP A 39 CYS A 40 TRP A 70 VAL A 106
SITE 2 AC1 11 GLU A 107 SER A 108 ILE A 109 HOH A 314
SITE 3 AC1 11 TRP B 39 FFN B 201 HOH B 484
SITE 1 AC2 14 GLU A 52 LYS A 56 PRO A 135 ASP A 136
SITE 2 AC2 14 HOH A 357 HOH A 361 HOH A 369 HOH A 398
SITE 3 AC2 14 TRP C 39 CYS C 40 PRO C 41 ILE C 109
SITE 4 AC2 14 HOH C 348 HOH C 442
SITE 1 AC3 15 TRP A 39 FFN A 201 ALA B 37 SER B 38
SITE 2 AC3 15 TRP B 39 PRO B 41 PRO B 42 CYS B 43
SITE 3 AC3 15 ARG B 44 TRP B 70 VAL B 106 GLU B 107
SITE 4 AC3 15 SER B 108 ILE B 109 HOH B 391
CRYST1 39.630 96.009 48.276 90.00 96.57 90.00 P 1 21 1 6
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.025233 0.000000 0.002904 0.00000
SCALE2 0.000000 0.010416 0.000000 0.00000
SCALE3 0.000000 0.000000 0.020851 0.00000